Skip to content

Healthcare Economist

Unbiased Analysis of Today's Healthcare Issues

Facebook Twitter Google Plus Linkedin Instagram YouTube Pinterest Tumblr VK
  • About the Author
  • Accolades
  • Archives
  • Contact
  • Subscribe

Month: April 2020

Quotation of the Day: On IQ

30 April 2020Jason ShafrinLeave a comment

Being enthusiastic is worth 25 IQ points. The Technium, “68 Bits of Unsolicited Advice“

Read More

Some good news in the fight against COVID-19

29 April 2020Jason Shafrin1 Comment

Looks like remdesivir had some positive results against COVID-19. As reported in STAT news: The preliminary data showed that the time to recovery was 11 days on remdesivir compared to 15 days for placebo, a 31% decrease. The mortality rate for the remdesivir group was 8%, compared to 11.6% for the placebo group; that mortality…

Read More

Could COVID-19 be a financial boon to health insurers?

28 April 2020Jason Shafrin1 Comment

Treating serious cases of COVID-19 is expensive. Treatment may require ICU beds, ventilators and lots of specialized staff time. So clearly, COVID-19 is destroying health insurers bottom lines…isn’t it? Not according to a recent article by Kaiser Health News. Because of the quarantine, many individuals are delaying or foregoing elective surgeries. Of course, the costs…

Read More

Are value-based agreements the solution to high drug prices?

27 April 2020Jason ShafrinLeave a comment

Drug prices are high. We should only be paying high prices for drugs that have a major impact on patient health and quality of life. Ergo, we should be paying for drugs with value-based agreements (VBAs), right? It turns out the answer is not so simple. A paper by Dubois, Westrich and Buelt (2020) argue…

Read More

Friday Links

24 April 202023 April 2020Jason ShafrinLeave a comment

Falling drug sales. Health benefits of car culture? The second wave? Opioid addiction treatment moves online. Life insurance and COVID-19. Allow pharmacists to test for COVID-19.

Read More

Critical Causal Inference Assumptions

23 April 202023 April 2020Jason ShafrinLeave a comment

You have data. You see that when people receive an intervention, the outcomes differ. Is this effect causal? For this to be the case you need 4 critical assumptions. Stable Unit Treatment Value Assumption (SUTVA).  This assumes that each treated unit does not affect other units.  For instance, consider the case where you imposed a…

Read More

Financial Check-up for Medicare and Social Security

22 April 202022 April 2020Jason Shafrin2 Comments

Today, the Trustees of the Social Security and Medicare trust funds released their 2020 report on the financial status of both programs (report, summary). The numbers don’t look good. I say this noting also that the projections do not take into account any impacts on mortality, health care costs and taxes revenue from COVID-19. Thus,…

Read More

How to deal with treatment switching when analyzing real-world evidence

21 April 2020Jason ShafrinLeave a comment

Is treatment A better than treatment B? This is a standard question in health economics. Typically, the answer is determined by a clinical trial. Treatment efficacy (as measured in a trial), however, may not match treatment effectiveness (as measured in the real world). For instance, patient adherence to treatment may be worse, if the treatment…

Read More

Things we know about health economics due to Amy Finkelstein

19 April 2020Jason Shafrin1 Comment

MIT Technology Review has an interesting profile of Amy Finkelstein, an MIT professor and one of my favorite health economists. [Full disclosure: I’ve never met Amy Finkelstein, I just enjoy her research]. The article is interesting throughout, but below I excerpt a sidebar showing 8 things that we know about health economics due to Finkelstein’s…

Read More

Friday Links

17 April 202016 April 2020Jason ShafrinLeave a comment

Retail after COVID. Is California a COVID success story or an impending disaster? Trump halts funding to WHO. Why everyone dies too early.  No sports in LA until 2021? Debt > 100% GDP?

Read More

Posts navigation

Page 1 Page 2 Next

Blogroll

  • Barry Shafrin
  • Becker-Posner
  • Brew Crew Ball
  • Cato Blog
  • Courtside Analyst
  • Covert Rationing
  • Drug Truths (John LaMattina)
  • Econbrowser
  • EconLog
  • Economist, The
  • Elle Jae Jewels
  • Ezra Klein
  • Free exchange
  • Global Financial Data
  • Goolge News: HealthCare
  • Hacking Healthcare
  • HC Policy & Marketplace Rev
  • Health Affairs Blog
  • Health Business Blog
  • Health Care Blog
  • Health Policy Wonk
  • Healthcare Technology News
  • HealthInsurance.org Blog
  • JASON SHAFRIN's Homepage
  • John Goodman
  • la Vanguardia
  • Marginal Revolution
  • Marketplace (NPR)
  • Medical Rants
  • Megan McArdle
  • Retired Doc’s Thoughts
  • Running a Hospital
  • Statistical Modeling
  • The Treatment
  • Wing of Zock
  • WonkBlog

Archives

  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • February 2006
  • January 2006

Search

Below Post




© 2021 Healthcare Economist | WordPress Theme: Drento by CrestaProject.